Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:July 28, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:July 28, 2022Recruiting
Condition(s):Chemotherapy-induced Nausea and Vomiting; Lung CancerLast Updated:July 13, 2021Unknown status
Condition(s):SchizophreniaLast Updated:April 7, 2015Completed
Condition(s):Negative Symptoms in SchizophreniaLast Updated:February 12, 2024Completed
Condition(s):Bipolar DisorderLast Updated:May 29, 2013Completed
Condition(s):SchizophreniaLast Updated:September 2, 2009Completed
Condition(s):Schizophrenia; Bipolar DisorderLast Updated:November 6, 2007Completed
Condition(s):Advanced CancerLast Updated:September 27, 2011Completed
Condition(s):Gynecologic CancerLast Updated:February 28, 2024Active, not recruiting
Condition(s):Substance Withdrawal SyndromeLast Updated:July 10, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.